Stanford researchers uncover key to overcoming chemoresistance in pancreatic cancer

FHS
July 5, 2024
12:33 am

Pancreatic cancer is a particularly aggressive and difficult-to-treat cancer, in part because it is often resistant to chemotherapy.

STRIDE Regimen Shows Manageable Safety in Unresectable Liver Cancer

The use of single tremelimumab (Imjudo) and regular interval durvalumab (Imfinzi; STRIDE regimen) in patients with unresectable hepatocellular carcinoma (HCC) showed manageable and low-grade immune-mediated

July 8, 2023

T-TEER shows promising outcomes in severe tricuspid regurgitation patients after one year

Tricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduced the severity of secondary tricuspid regurgitation and improved quality of life after 1 year, according to late-breaking research

September 1, 2024

Umoja’s $100M Series C will advance its bid for more convenient cell therapies

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 15, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.